Sylogist Valuation
| SYZ Stock | CAD 8.72 0.52 6.34% |
At this time, the company appears to be undervalued. Sylogist has a current Real Value of C$9.18 per share. The regular price of the company is C$8.72. Our model measures the value of Sylogist from inspecting the company fundamentals such as Operating Margin of 0.04 %, shares outstanding of 23.41 M, and Return On Equity of -0.0335 as well as reviewing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Sylogist's valuation include:
Price Book 5.4581 | Enterprise Value | Enterprise Value Ebitda 17.9719 | Price Sales 2.8892 | Forward PE 62.8931 |
Undervalued
Today
Please note that Sylogist's price fluctuation is somewhat reliable at this time. Calculation of the real value of Sylogist is based on 3 months time horizon. Increasing Sylogist's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Sylogist is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Sylogist Stock. However, Sylogist's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 8.72 | Real 9.18 | Hype 8.72 |
The intrinsic value of Sylogist's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Sylogist's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Sylogist helps investors to forecast how Sylogist stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Sylogist more accurately as focusing exclusively on Sylogist's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Sylogist's intrinsic value based on its ongoing forecasts of Sylogist's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Sylogist's closest peers.
Sylogist Cash |
|
Sylogist Valuation Trend
Knowing Sylogist's actual value is paramount for traders when making sound investment determinations. Using both Sylogist's enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.
Sylogist Total Value Analysis
Sylogist is at this time forecasted to have takeover price of 197.87 M with market capitalization of 191.95 M, debt of 17.74 M, and cash on hands of 0. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Sylogist fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
197.87 M | 191.95 M | 17.74 M | 0 |
Sylogist Investor Information
About 35.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 0.05. Sylogist last dividend was issued on the 28th of February 2025. The entity had 1:7 split on the 4th of December 2002. Based on the key indicators related to Sylogist's liquidity, profitability, solvency, and operating efficiency, Sylogist may be sliding down financialy. It has an above-average chance of going through some form of financial crunch next quarter.Sylogist Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Sylogist has an asset utilization ratio of 67.84 percent. This suggests that the Company is making C$0.68 for each dollar of assets. An increasing asset utilization means that Sylogist is more efficient with each dollar of assets it utilizes for everyday operations.Sylogist Ownership Allocation
Sylogist shows a total of 23.41 Million outstanding shares. 30% of Sylogist outstanding shares are owned by institutional holders. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Sylogist Profitability Analysis
The company reported the revenue of 65.51 M. Net Income was 1.1 M with profit before overhead, payroll, taxes, and interest of 39.16 M.Sylogist Past Distributions to stockholders
About Sylogist Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Sylogist. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Sylogist based exclusively on its fundamental and basic technical indicators. By analyzing Sylogist's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Sylogist's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Sylogist. We calculate exposure to Sylogist's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Sylogist's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 33.8 M | 35.5 M | |
| Pretax Profit Margin | (0.04) | (0.04) | |
| Operating Profit Margin | 0.01 | 0.01 | |
| Net Profit Margin | 0.02 | 0.01 | |
| Gross Profit Margin | 0.40 | 0.50 |
Other Information on Investing in Sylogist Stock
Sylogist financial ratios help investors to determine whether Sylogist Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sylogist with respect to the benefits of owning Sylogist security.